首頁 > 市場調查報告書 > 醫療設備

生技設備

空間體學市場規模、佔有率和成長分析（按技術、產品、工作流程、樣本類型、最終用途和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1898613

空間體學市場規模、佔有率和成長分析（按技術、產品、工作流程、樣本類型、最終用途和地區分類）－2026-2033年產業預測

Spatial Omics Market Size, Share, and Growth Analysis, By Technology (Spatial Transcriptomics, Spatial Genomics), By Product (Instruments, Consumables), By Workflow, By Sample Type, By End-use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球空間體學市場規模將達到 4029.6 億美元，到 2025 年將達到 4,448.7 億美元，到 2033 年將達到 9,817.1 億美元，預測期（2026-2033 年）的複合年成長率為 10.4%。

全球空間體學市場正經歷強勁成長，這主要得益於定序技術的進步、創新研究投入的增加以及遺傳疾病發生率的上升。從基因定序轉向透過空間表現型分析細胞類型和生物標記相互作用是這一發展過程中的關鍵一步。市場上的主要企業提供多樣化的解決方案，能夠定量分析約1800個RNA靶標，有效地將組織內的分子分析與空間細胞背景結合。這種空間基因組資訊已被證明在疾病診斷中至關重要，因為它可作為識別病理狀況的生物標記。此外，這項技術正在加深我們對關鍵生物學過程（例如組織結構和細胞調控）的理解，從而改變我們治療和管理疾病的方法。

全球空間體學市場促進因素

隨著人們尋求了解和識別那些常常代代相傳的遺傳疾病，全球對空間體學工具的需求正在激增。這一趨勢的驅動力在於人們渴望揭開遺傳疾病及其潛在機制的不確定性。隨著越來越多的人意識到滲透技術在診斷和研究這些疾病方面的潛在優勢，人們對先進的空間體學解決方案的興趣也持續成長。因此，空間體學市場不斷擴張，反映出人們越來越認知到先進技術工具在增進我們對複雜生物系統和疾病管理的理解方面所發揮的作用。

限制全球空間體學市場的因素

全球空間體學市場面臨許多挑戰，可能阻礙其擴張。其中一個主要阻礙因素是該新興領域研究專長有限，這可能會扼殺創新和發展。此外，由於空間體學研究仍處於起步階段，尚未被研究人員和從業人員廣泛接受，這阻礙了其融入主流科學研究。這種知識和理解的匱乏可能會降低市場採納率，並限制市場的整體成長潛力，因為相關人員可能不願意投資於一個相對未知的研究領域。

全球空間體學市場趨勢

全球空間體學市場正經歷顯著成長，這主要得益於對能夠更深入了解腫瘤微環境和細胞相互作用的先進診斷技術的需求不斷成長。隨著研究人員和醫療保健提供者認知到早期檢測惡性腫瘤的重要性，空間體學正逐漸成為揭示腫瘤界面病理機制的重要工具。高通量技術與生物資訊學的融合進一步加速了空間體學的應用，使其能夠對細胞圖譜進行精確分析。這一趨勢促進了生物技術公司與學術機構之間的合作，最終為創新治療策略的開發和患者預後的改善鋪平了道路。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

10x Genomics（US）
Illumina（US）
Fluidigm Corporation（US）
Akoya Biosciences（formerly PerkinElmer）（US）
S2 Genomics, Inc.（US）
RareCyte, Inc.（US）
ZEISS Group（Germany）
Miltenyi Biotec（Germany）
Bio-Techne Corporation（US）
Visiopharm（Denmark）
Indica Labs, Inc.（US）
Bio-Rad Laboratories, Inc.（US）
Oxford Nanopore Technologies（UK）
Takara Bio Inc.（Japan）

結論與建議

簡介目錄

Product Code: SQMIG35H2069

Global Spatial Omics Market size was valued at USD 402.96 Billion in 2024 and is poised to grow from USD 444.87 Billion in 2025 to USD 981.71 Billion by 2033, growing at a CAGR of 10.4% during the forecast period (2026-2033).

The global spatial omics market is experiencing robust growth driven by advancements in sequencing technology, increased investment in innovative research, and the rising incidence of genetic disorders. The shift from decoding genes to analyzing cell types and biomarker interactions through spatial phenotyping is pivotal in this evolution. Key players in the market are providing diverse solutions that facilitate the quantification of around 1,800 RNA targets, effectively merging molecular analysis with spatial cellular context within tissues. This spatial genomic information is proving vital in diagnosing diseases, as it serves as a biomarker to identify medical conditions. Moreover, this technology is enhancing our understanding of critical biological processes, such as tissue organization and cellular regulation, thereby transforming approaches to disease treatment and management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Spatial Omics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Spatial Omics Market Segments Analysis

Global Spatial Omics Market is segmented by Technology, Product, Workflow, Sample Type, End-use and region. Based on Technology, the market is segmented into Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics. Based on Product, the market is segmented into Instruments, Consumables and Software. Based on Workflow, the market is segmented into Sample Preparation, Instrumental Analysis and Data Analysis. Based on Sample Type, the market is segmented into FFPE and Fresh Frozen. Based on End-use, the market is segmented into Academic & Translational Research Institutes and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Spatial Omics Market

The global demand for spatial omics tools has surged as individuals seek to understand and identify genetic disorders that are often passed down through generations. This drive is fueled by the desire to clarify uncertainties surrounding hereditary diseases and their underlying mechanisms. As more people become aware of the potential benefits of osmotic technology in diagnosing and researching these conditions, the interest in sophisticated spatial omics solutions continues to grow. Consequently, the market for spatial omics is expanding, reflecting an increasing appreciation for the role of advanced technological tools in enhancing our understanding of complex biological systems and disease management.

Restraints in the Global Spatial Omics Market

The Global Spatial Omics market faces several challenges that may inhibit its expansion. A key constraint is the limited availability of research expertise in this emerging field, which can stifle innovation and development. Additionally, the nascent nature of spatial omics research leads to a lack of widespread acceptance among researchers and practitioners, creating barriers to its integration into mainstream scientific studies. This scarcity of knowledge and familiarity can slow adoption rates and limit the overall growth potential of the market, as stakeholders may be hesitant to invest in a relatively uncharted area of study.

Market Trends of the Global Spatial Omics Market

The Global Spatial Omics market is witnessing significant growth, driven by the increasing demand for advanced diagnostic techniques that enhance the understanding of tumor microenvironments and cellular interactions. As researchers and healthcare providers recognize the importance of early malignancy detection, spatial omics is emerging as a pivotal tool for elucidating pathological mechanisms at the tumor boundary. The integration of high-throughput technologies and bioinformatics further accelerates the adoption of spatial omics, facilitating precise analysis of cellular landscapes. This trend is fostering collaborations between biotechnology firms and academic institutions, ultimately paving the way for innovative therapeutic strategies and improved patient outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global Spatial Omics Market Size by Technology & CAGR (2026-2033)

Market Overview
Spatial Transcriptomics
Spatial Genomics
Spatial Proteomics

Global Spatial Omics Market Size by Product & CAGR (2026-2033)

Market Overview
Instruments
- By Mode
- Automated
- Semi-automated
- Manual
- By Type
- Sequencing Platforms
- IHC
- Microscopy
- Flow Cytometry
- Mass Spectrometry
- Others
Consumables
Software
- Bioinformatics Tools
- Imaging Tools
- Storage & Management Databases

Global Spatial Omics Market Size by Workflow & CAGR (2026-2033)

Market Overview
Sample Preparation
Instrumental Analysis
Data Analysis

Global Spatial Omics Market Size by Sample Type & CAGR (2026-2033)

Market Overview
FFPE
Fresh Frozen

Global Spatial Omics Market Size by End-use & CAGR (2026-2033)

Market Overview
Academic & Translational Research Institutes
Pharmaceutical & Biotechnology Companies

Global Spatial Omics Market Size & CAGR (2026-2033)

North America (Technology, Product, Workflow, Sample Type, End-use)
- US
- Canada
Europe (Technology, Product, Workflow, Sample Type, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Product, Workflow, Sample Type, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Product, Workflow, Sample Type, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Product, Workflow, Sample Type, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

10x Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Akoya Biosciences (formerly PerkinElmer) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
S2 Genomics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RareCyte, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZEISS Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Visiopharm (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indica Labs, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments